Condition
Healthy Female Subjects
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06740253Not ApplicableCompletedPrimary
Safety and Acceptability Study of a Placebo Antibody-Based Nonhormonal Contraceptive Intravaginal Ring
NCT03792893Not ApplicableCompletedPrimary
Comparison of Pulse Wave and Blood Pressure Measurements Before, During and After Ergometry in Healthy Women
NCT01053520Phase 1CompletedPrimary
Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female Subjects
Showing all 3 trials